GEHC
RDNT
The AI mammogram arms race
GE HealthCare just deepened its tie-up with DeepHealth, the AI informatics subsidiary of RadNet, to boost the innovation, commercialization, and adoption of AI-powered mammography tools. In plain English: the company wants to make breast cancer screening smarter, faster, and a lot more scalable.
Why this matters
This isn’t just a shiny partnership press release with a buzzword buffet. GEHC has been steadily trying to turn imaging into a more software-flavored business, and AI is the cheat code everyone in medtech wants on the board right now. If this works, it could help GEHC create more recurring revenue, strengthen customer relationships, and make its breast imaging lineup harder to rip out later.
The investor angle
The collaboration also fits a bigger theme in healthcare tech: the race to own the workflow, not just the machine. That’s the difference between selling a scanner and becoming part of the hospital’s day-to-day operating system. DeepHealth brings the AI layer, GE HealthCare brings the reach and installed base, and together they’re trying to make mammography less of a clunky checkpoint and more of a streamlined pipeline.
Big picture
For shareholders, this is less about a single quarterly pop and more about GEHC showing it wants to be a platform, not just a product catalog. If AI keeps sticking in clinical workflows, investors may start valuing these partnerships like growth engines instead of nice-to-have side quests.